134 related articles for article (PubMed ID: 22185941)
41. Primaquine and relapses of Plasmodium vivax. Meta analysis of controlled clinical trials.
Carmona Fonseca J
Rev Bras Epidemiol; 2015; 18(1):174-93. PubMed ID: 25651020
[TBL] [Abstract][Full Text] [Related]
42. Cytochrome P450 2D-mediated metabolism is not necessary for tafenoquine and primaquine to eradicate the erythrocytic stages of Plasmodium berghei.
Milner EE; Berman J; Caridha D; Dickson SP; Hickman M; Lee PJ; Marcsisin SR; Read LT; Roncal N; Vesely BA; Xie LH; Zhang J; Zhang P; Li Q
Malar J; 2016 Dec; 15(1):588. PubMed ID: 27923405
[TBL] [Abstract][Full Text] [Related]
43. Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine.
Daher A; Aljayyoussi G; Pereira D; Lacerda MVG; Alexandre MAA; Nascimento CT; Alves JC; da Fonseca LB; da Silva DMD; Pinto DP; Rodrigues DF; Silvino ACR; de Sousa TN; de Brito CFA; Ter Kuile FO; Lalloo DG
Malar J; 2019 Sep; 18(1):325. PubMed ID: 31547827
[TBL] [Abstract][Full Text] [Related]
44. A randomised trial of an eight-week, once weekly primaquine regimen to prevent relapse of plasmodium vivax in Northwest Frontier Province, Pakistan.
Leslie T; Mayan I; Mohammed N; Erasmus P; Kolaczinski J; Whitty CJ; Rowland M
PLoS One; 2008 Aug; 3(8):e2861. PubMed ID: 18682739
[TBL] [Abstract][Full Text] [Related]
45. Why are primaquine and other 8-aminoquinolines particularly effective against the mature gametocytes and the hypnozoites of malaria?
Warhurst DC
Ann Trop Med Parasitol; 1984 Apr; 78(2):165. PubMed ID: 6378110
[No Abstract] [Full Text] [Related]
46. Is primaquine useful and safe as true exo-erythrocytic merontocidal, hypnozoitocidal and gametocidal antimalarial drug?
López-Antuñano FJ
Salud Publica Mex; 1999; 41(5):410-9. PubMed ID: 11142837
[TBL] [Abstract][Full Text] [Related]
47. Enantioselective metabolism of primaquine by human CYP2D6.
Fasinu PS; Tekwani BL; Nanayakkara NP; Avula B; Herath HM; Wang YH; Adelli VR; Elsohly MA; Khan SI; Khan IA; Pybus BS; Marcsisin SR; Reichard GA; McChesney JD; Walker LA
Malar J; 2014 Dec; 13():507. PubMed ID: 25518709
[TBL] [Abstract][Full Text] [Related]
48. Diagnostic and therapeutic pitfalls associated with primaquine-tolerant Plasmodium vivax.
Spudick JM; Garcia LS; Graham DM; Haake DA
J Clin Microbiol; 2005 Feb; 43(2):978-81. PubMed ID: 15695723
[TBL] [Abstract][Full Text] [Related]
49. [In vitro dissolution profile of primaquine tablets available for malaria treatment in Brazil].
Rodrigues LN; Watanabe SP; Ferraz HG
Rev Soc Bras Med Trop; 2008; 41(1):41-5. PubMed ID: 18368269
[TBL] [Abstract][Full Text] [Related]
50. PFMDR1 POLYMORPHISMS INFLUENCE ON IN VITRO SENSITIVITY OF THAI PLASMODIUM FALCIPARUM ISOLATES TO PRIMAQUINE, SITAMAQUINE AND TAFENOQUINE.
Kaewpruk N; Tan-ariya P; Ward SA; Sitthichot N; Suwandittakul N; Mungthin M
Southeast Asian J Trop Med Public Health; 2016 May; 47(3):366-76. PubMed ID: 27405118
[TBL] [Abstract][Full Text] [Related]
51. Targeting primaquine into liver using chylomicron emulsions for potential vivax malaria therapy.
Dierling AM; Cui Z
Int J Pharm; 2005 Oct; 303(1-2):143-52. PubMed ID: 16140485
[TBL] [Abstract][Full Text] [Related]
52. Plasmodium vivax infections in U.S. Army troops: failure of primaquine to prevent relapse in studies from Somalia.
Smoak BL; DeFraites RF; Magill AJ; Kain KC; Wellde BT
Am J Trop Med Hyg; 1997 Feb; 56(2):231-4. PubMed ID: 9080885
[TBL] [Abstract][Full Text] [Related]
53. Antimalarial and anti-inflammatory activities of new chloroquine and primaquine hybrids: Targeting the blockade of malaria parasite transmission.
Boechat N; Carvalho RCC; Ferreira MLG; Coutinho JP; Sa PM; Seito LN; Rosas EC; Krettli AU; Bastos MM; Pinheiro LCS
Bioorg Med Chem; 2020 Dec; 28(24):115832. PubMed ID: 33166927
[TBL] [Abstract][Full Text] [Related]
54. Studies on a primaquine-tolerant strain of Plasmodium vivax from Brazil in Aotus and Saimiri monkeys.
Nayar JK; Baker RH; Knight JW; Sullivan JS; Morris CL; Richardson BB; Galland GG; Collins WE
J Parasitol; 1997 Aug; 83(4):739-45. PubMed ID: 9267419
[TBL] [Abstract][Full Text] [Related]
55. Antimalarial drug resistance: an increasing problem.
Peters W
Br Med Bull; 1982 May; 38(2):187-92. PubMed ID: 7052200
[No Abstract] [Full Text] [Related]
56. A (polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer)-dispersed sustained-release tablet for imperialine to simultaneously prolong the drug release and improve the oral bioavailability.
Lin Q; Fu Y; Li J; Qu M; Deng L; Gong T; Zhang Z
Eur J Pharm Sci; 2015 Nov; 79():44-52. PubMed ID: 26349052
[TBL] [Abstract][Full Text] [Related]
57. Primaquine treatment for Plasmodium vivax--an essential tool for malaria control and elimination in Papua New Guinea.
Betuela I; Robinson LJ; Hetzel MW; Laman M; Siba PM; Bassat Q; Mueller I
P N G Med J; 2014; 57(1-4):68-74. PubMed ID: 26930890
[TBL] [Abstract][Full Text] [Related]
58. Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial.
Mwaiswelo R; Ngasala B; Jovel I; Aydin-Schmidt B; Gosling R; Premji Z; Mmbando B; Björkman A; Mårtensson A
Malar J; 2016 Aug; 15(1):435. PubMed ID: 27565897
[TBL] [Abstract][Full Text] [Related]
59. Development and In Vitro-In Vivo Correlation Evaluation of IMM-H014 Extended-Release Tablets for the Treatment of Fatty Liver Disease.
Zhang C; Shao H; Han Z; Liu B; Feng J; Zhang J; Zhang W; Zhang K; Yang Q; Wu S
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569704
[TBL] [Abstract][Full Text] [Related]
60. Primaquine for radical cure of Plasmodium vivax and Plasmodium ovale malaria: an observational survey (2008-2010).
Faucher JF; Bellanger AP; Chirouze C; Hustache-Mathieu L; Genton S; Hoen B
J Travel Med; 2013; 20(2):134-6. PubMed ID: 23464724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
